Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
Beaver-Visitec said today it acquired U.K.-based single-use ophthalmology surgical instrument maker Malosa Medical for an undisclosed amount.
Malosa Medical has a portfolio of more than 400 products, according to Beaver-Visitec. Malosa packages its sets in sterilized, single-use packs which contain all required instruments and consumables for specific ophthalmic procedures, including cataract surgery and intravitreal injections, BVI added. Read more
Abbott has issued an urgent field safety notice looking to recall select coronary dilation and balloon catheters over issues with inflating and deflating the balloons.
The company said it is recalling specific lots of the NC Trek RX coronary dilation catheter, the NC Traveler RX coronary dilation catheter and the NC Tenku RX PTCA balloon catheter over issues with removing the protective balloon sheath which can result in issues inflating or deflating the balloon. Read more
Johnson & Johnson subsidiary DePuy Synthes said today it acquired 3D printing technology assets from Tissue Regeneration Systems for an undisclosed amount.
DePuy said it will use the technology to create patient-specific, bioresorbable implants for correcting orthopedic and craniomaxillofacial deformities and injuries. Read more
Revolutions Medical CEO Ron Wheet has been found not guilty of allegations of filing false stock registration statements, according to Charleston, S.C.’s Post & Courier.
The case was based around allegations that Wheet and former investor relations head Bryon Key issues more than 1.2 million shares of company stock to at least 11 people using false SEC filings, according to the paper. Read more
Shares in General Electric fell today despite the industrial conglomerate beating expectations on The Street and posting solid gains for its healthcare division.
GE reported profits of $577 million, or 7¢ per share, on sales of $27.7 billion for the 3 months ended March 31, for bottom-line gains of over 400% while sales shrunk 0.7% compared with the same period in 2016. Read more